ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) Director Robert John Andrew Ryan acquired 4,313 shares of the stock in a transaction that occurred on Monday, April 29th. The shares were acquired at an average cost of $3.20 per share, with a total value of $13,801.60. Following the transaction, the director now owns 555,868 shares in the company, valued at $1,778,777.60. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Robert John Andrew Ryan also recently made the following trade(s):
- On Thursday, April 25th, Robert John Andrew Ryan bought 9,500 shares of ASP Isotopes stock. The stock was bought at an average price of $3.42 per share, with a total value of $32,490.00.
ASP Isotopes Stock Performance
ASPI stock opened at $3.16 on Thursday. The stock's fifty day moving average is $3.73 and its two-hundred day moving average is $2.54. The stock has a market capitalization of $154.59 million, a price-to-earnings ratio of -6.45 and a beta of 5.03. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.85 and a current ratio of 1.85. ASP Isotopes Inc. has a 1 year low of $0.28 and a 1 year high of $4.97.
ASP Isotopes (NASDAQ:ASPI - Get Free Report) last posted its earnings results on Wednesday, April 10th. The company reported ($0.09) earnings per share (EPS) for the quarter. The business had revenue of $0.43 million for the quarter. On average, research analysts predict that ASP Isotopes Inc. will post -0.11 EPS for the current year.
Analyst Upgrades and Downgrades
Elon to Transform U.S. Economy?
From Porter & Company | Ad
A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
One company holds a near-total monopoly on it.
Separately, HC Wainwright raised their price target on ASP Isotopes from $5.25 to $5.50 and gave the stock a "buy" rating in a report on Wednesday, April 17th.
View Our Latest Stock Analysis on ASP Isotopes
Institutional Inflows and Outflows
An institutional investor recently bought a new position in ASP Isotopes stock. Rathbones Group PLC bought a new position in ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 151,750 shares of the company's stock, valued at approximately $272,000. Rathbones Group PLC owned 0.31% of ASP Isotopes as of its most recent SEC filing. Institutional investors and hedge funds own 16.80% of the company's stock.
About ASP Isotopes
(
Get Free Report)
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
